Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0021051,
umls-concept:C0079864,
umls-concept:C0185117,
umls-concept:C0205161,
umls-concept:C0330390,
umls-concept:C0591833,
umls-concept:C0599991,
umls-concept:C0851285,
umls-concept:C1415900,
umls-concept:C1552644,
umls-concept:C1823153,
umls-concept:C2349976,
umls-concept:C2911684
|
pubmed:issue |
10
|
pubmed:dateCreated |
1988-12-8
|
pubmed:abstractText |
Mice infected with LP-BM5 murine leukemia viruses (MuLV) develop a syndrome with many features in common with AIDS including lymphadenopathy and profound immunodeficiency associated with enhanced susceptibility to infection and terminal B cell lymphomas. To evaluate cellular defects that may predispose infected mice to these sequelae, we studied the regulation of IFN gene expression. Spleen cells from mice infected with LP-BM5 MuLV expressed high levels of IFN-gamma mRNA by 1 wk post-inoculation and throughout the course of disease. By comparison, transcripts of IFN-alpha/beta genes were not detected in spleen cells at any time after infection. In uninfected mice, expression of IFN-alpha/beta genes is induced rapidly after infection with New-castle disease virus, but mice inoculated with LP-BM5 MuLV were unable to induce these genes by 4 wk after retroviral infection. Inhibition of IFN-alpha/beta induction due to LP-BM5 MuLV infection also occurred in nude mice, indicating this effect was not mediated by activated T cells. Furthermore, low levels of IFN-gamma transcripts were detected in spleens of nude infected mice, suggesting that cells other than T cells can express this gene. These results suggest that the normal contributions of IFN to control of microbial spread, immune surveillance, and lymphoid interactions are disrupted by infection with LP-BM5 MuLV.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
141
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
3611-6
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:2846690-Animals,
pubmed-meshheading:2846690-Immunologic Deficiency Syndromes,
pubmed-meshheading:2846690-Interferon Type I,
pubmed-meshheading:2846690-Interferon-gamma,
pubmed-meshheading:2846690-Leukemia, Experimental,
pubmed-meshheading:2846690-Mice,
pubmed-meshheading:2846690-Mice, Inbred C57BL,
pubmed-meshheading:2846690-Mink Cell Focus-Inducing Viruses,
pubmed-meshheading:2846690-RNA, Messenger,
pubmed-meshheading:2846690-Retroviridae Infections,
pubmed-meshheading:2846690-Spleen
|
pubmed:year |
1988
|
pubmed:articleTitle |
Abnormal regulation of IFN-alpha, -beta, and -gamma expression in MAIDS, a murine retrovirus-induced immunodeficiency syndrome.
|
pubmed:affiliation |
Johns Hopkins University Oncology Center, Baltimore, MD 21205.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|